Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness

ACS Chemical Biology

Volumn 9, Issue 6, 2014, Pages 1340-1350

  Benjamin, Daniel I ^a   Louie, Sharon M ^a   Mulvihill, Melinda M ^a   Kohnz, Rebecca A ^a   Li, Daniel S ^a   Chan, Lauryn G ^a   Sorrentino, Antonio ^b   Bandyopadhyay, Sourav ^c   Cozzo, Alyssa ^a   Ohiri, Anayo ^a   Goga, Andrei ^b,c   Ng, Shu Wing ^d   Nomura, Daniel K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; GLYCERALDEHYDE 3 PHOSPHATE; GLYCEROPHOSPHATE; HEXOKINASE; INOSITOL POLYPHOSPHATE; INOSITOL POLYPHOSPHATE PHOSPHATASE 1; LYSOPHOSPHATIDIC ACID; UNCLASSIFIED DRUG; INOSITOL PHOSPHATE; INOSITOL-1,4-BISPHOSPHATE 1-PHOSPHATASE; PHOSPHATASE; SMALL INTERFERING RNA;

AGGRESSIVENESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CARCINOGENICITY; CELL FUNCTION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MELANOMA; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, PAPILLARY; CELL MOTION; CYSTADENOCARCINOMA, SEROUS; DRUG EFFECTS; GENETICS; METABOLISM; METABOLOME; NEOPLASMS; OVARIAN NEOPLASMS; PATHOLOGY; SCID MOUSE; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL MOVEMENT; CELL PROLIFERATION; CYSTADENOCARCINOMA, SEROUS; FEMALE; GLYCOLYSIS; HUMANS; INOSITOL PHOSPHATES; LIPID METABOLISM; METABOLOME; MICE; MICE, SCID; NEOPLASMS; OVARIAN NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84903131071     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb5001907     Document Type: Article

References (22)

1. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324, 1029-1033
2. Benjamin, D. I., Cravatt, B. F., and Nomura, D. K. (2012) Global profiling strategies for mapping dysregulated metabolic pathways in cancer Cell Metab. 16, 565-577
3. Nomura, D. K., Lombardi, D. P., Chang, J. W., Niessen, S., Ward, A. M., Long, J. Z., Hoover, H. H., and Cravatt, B. F. (2011) Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer Chem. Biol. 18, 846-856
4. Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S. W., and Cravatt, B. F. (2010) Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis Cell 140, 49-61
5. Chiang, K. P., Niessen, S., Saghatelian, A., and Cravatt, B. F. (2006) An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling Chem. Biol. 13, 1041-1050 (Pubitemid 44557068)
6. Chang, J. W., Nomura, D. K., and Cravatt, B. F. (2011) A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis Chem. Biol. 18, 476-484
7. Inhorn, R. C. and Majerus, P. W. (1987) Inositol polyphosphate 1-phosphatase from calf brain. Purification and inhibition by Li+, Ca2+, and Mn2+ J. Biol. Chem. 262, 15946-15952
8. Li, S. R., Gyselman, V. G., Lalude, O., Dorudi, S., and Bustin, S. A. (2000) Transcription of the inositol polyphosphate 1-phosphatase gene (INPP1) is upregulated in human colorectal cancer Mol. Carcinog. 27, 322-329 (Pubitemid 30192002)
9. Sethi, N. and Kang, Y. (2011) Unravelling the complexity of metastasis-molecular understanding and targeted therapies Nat. Rev. Cancer 11, 735-748
10. Nguyen, D. X., Bos, P. D., and Massague, J. (2009) Metastasis: from dissemination to organ-specific colonization Nat. Rev. Cancer 9, 274-284
11. Sebolt-Leopold, J. S. and Herrera, R. (2004) Targeting the mitogen-activated protein kinase cascade to treat cancer Nat. Rev. Cancer 4, 937-947 (Pubitemid 39626217)
12. Tautenhahn, R., Patti, G. J., Rinehart, D., and Siuzdak, G. (2012) XCMS Online: a web-based platform to process untargeted metabolomic data Anal. Chem. 84, 5035-5039
13. Mills, G. B. and Moolenaar, W. H. (2003) The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3, 582-591 (Pubitemid 37328830)
14. Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., Yagi, M., Sato, M., Suzuki, R., Murooka, H., Sakai, T., Nishitoba, T., Im, D. S., Nochi, H., Tamoto, K., Tomura, H., and Okajima, F. (2003) Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64, 994-1005 (Pubitemid 37153068)
15. Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., and Thompson, C. B. (2004) Akt stimulates aerobic glycolysis in cancer cells Cancer Res. 64, 3892-3899 (Pubitemid 38697301)
16. Zhong, D. S., Xiong, L., Liu, T. R., Liu, X. J., Liu, X. G., Chen, J., Sun, S. Y., Khuri, F. R., Zong, Y. P., Zhou, Q. H., and Zhou, W. (2009) The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R J. Biol. Chem. 284, 23225-23233
17. Yu, F. X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., Fu, X. D., Mills, G. B., and Guan, K. L. (2012) Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling Cell 150, 780-791
18. Cai, H. and Xu, Y. (2013) The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells Cell Commun. Signaling 11, 31
19. Yang, W., Xia, Y., Cao, Y., Zheng, Y., Bu, W., Zhang, L., You, M. J., Koh, M. Y., Cote, G., Aldape, K., Li, Y., Verma, I. M., Chiao, P. J., and Lu, Z. (2012) EGFR-induced and PKCepsilon monoubiquitylation-dependent NF-kappaB activation upregulates PKM2 expression and promotes tumorigenesis Mol. Cell 48, 771-784
20. Babic, I., Anderson, E. S., Tanaka, K., Guo, D., Masui, K., Li, B., Zhu, S., Gu, Y., Villa, G. R., Akhavan, D., Nathanson, D., Gini, B., Mareninov, S., Li, R., Camacho, C. E., Kurdistani, S. K., Eskin, A., Nelson, S. F., Yong, W. H., Cavenee, W. K., Cloughesy, T. F., Christofk, H. R., Black, D. L., and Mischel, P. S. (2013) EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer Cell Metab. 17, 1000-1008
21. Jessani, N., Humphrey, M., McDonald, W. H., Niessen, S., Masuda, K., Gangadharan, B., Yates, J. R., Mueller, B. M., and Cravatt, B. F. (2004) Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo Proc. Natl. Acad. Sci. U.S.A. 101, 13756-13761 (Pubitemid 39298480)
22. Kopp, F., Komatsu, T., Nomura, D. K., Trauger, S. A., Thomas, J. R., Siuzdak, G., Simon, G. M., and Cravatt, B. F. (2010) The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1(-/-) mice Chem. Biol. 17, 831-840